Thygesons Superficial Punctate Keratitis (TSPK) Treatment and Management
Various treatments have been used to try and treat Thygeson’s SPK; however, many have been unsuccessful. Antibiotics are not successful and are ineffective in treating the condition. In some instances antivirals have been used and have had mixed results resulting in mild improvements with the use of trifluridine. Contrary information also suggests that the use […]
Cyclosporine Ophthalmic Emulsion 0.05% – Restatis by Allergan
Produced as a sterile, preservative-free emulsion made from a white powder, Cyclosporine acts as a topical immunomodulator that has an anti-inflammatory effect. While Cyclosporine is the active ingredient, there are a number of inactive ingredients including polysorbate 80, glycerin, carbomer copolymer type A, castor oil, purified water, and sodium hydroxide to adjust its pH level. […]
No Cyclosporine Eye Drops in the UK
There are benefits associated with the treatment of Thygeson’s SPK using Cyclosporine. However, it needs to be used at a low concentration level. The treatment appears beneficial, yet it is not marketed at low concentrations in the UK under the National Health Service. Discussions with a local consultant in Edinburgh suggests that while the long-term […]
Topical Therapy in Thygeson’s Superficial Punctate Keratitis
When someone is affected by the severity of Thygeson’s Superficial Punctate Keratitis or in any of its signs, symptoms, or following remission, various therapies are considered depending on the severity of the disease at the time the patient presents to the eye care specialist. Where a patient presents with a mild case, then they may […]
Corticosteroids and Cyclosporine Treatments for Thygeson’s SPK
Studying the opacities or lesions created by Thygeson’s SPK, also known as Thygeson’s Superficial Punctate Keratopathy, Thygeson’s Superficial Punctate Keratitis and TSPK, shows a crystalline appearance on the corneal surface that resemble snowflakes. They vary in location and fluctuate in numbers even on a weekly basis during a flare up of the condition affecting the […]
Thygeson’s Superficial Punctate Keratitis (TSPK) Disease Medical Care
Medical care for people diagnosed with Thygeson’s Superficial Punctate Keratitis (TSPK) varies depending on the severity of the condition in each individual. There are varieties of treatments that have been tried and many experimental therapies are being tested at different locations around the world. The fact is that many approaches have been taken to treat […]
The Pathophysiology of Thygeson’s SPK
Many specialists have studied the pathophysiology of Thygeson’s Superficial Punctate Keratitis (TSPK) by documenting all known biology and physical symptoms pertaining to patients. This disease has confounded medical doctors, researchers, and laboratory workers for decades. The knowledge gained since Phillips Thygeson first published a paper on TSPK in the AMA Journal in 1950 has mostly […]